Julie Meade, PhD, scientific writer, Global Scientific and Regulatory Documentation, collaborates with colleagues in her role at Bristol Myers Squibb
September 29, 2022
Voices from R&D: personal experience inspires the development of new medicines >
September 02, 2022
Exploring pathways in immune-mediated diseases to advance patient care >
Pioneering paths forward in immunology
June 23, 2022
Pioneering paths forward in immunology >
Lupus: Treatments, Research and Bristol Myers Squibb’s Dedication to Patients – A Q&A with Subhashis Banerjee
May 27, 2022
Lupus: Treatments, research and Bristol Myers Squibb’s dedication to patients – A Q&A With Subhashis Banerjee >
Kellie Calderon, MD, executive medical director
May 27, 2022
BMS’ commitment to precision medicine for patients living with immune-mediated diseases >
Jasmin, MS patient
February 24, 2022
Taking back control: multiple sclerosis patients preserve body and mind >
Winter Williams
February 14, 2022
Winter’s story: living with ulcerative colitis >
Raising Awareness Globally on World Psoriasis Day
October 28, 2021
Becoming united: raising awareness globally on World Psoriasis Day >
Asian scientist with microscope
August 20, 2021
The surprising science that connects immunology and oncology >
Diego Silva (left) vice president, Worldwide Medical, interim head of Immunology and Fibrosis and Cathy Traz (right), executive director, Bristol Myers Squibb Patient Advocacy
May 25, 2021
How BMS supports the MS community: a Q&A with Diego Silva and Cathy Trzaskawka >
May 13, 2021
Break the silence: shining a light on IBD >
A Q&A with Mark Osterman
May 13, 2021
Inflammatory bowel disease (IBD): research, partnerships and Bristol Myers Squibb’s dedication to patients >